Annual Current Liabilities
$655.30 K
-$464.60 K-41.49%
31 December 2023
Summary:
Protagenic Therapeutics annual total current liabilities is currently $655.30 thousand, with the most recent change of -$464.60 thousand (-41.49%) on 31 December 2023. During the last 3 years, it has risen by +$100.00 (+0.02%). PTIX annual current liabilities is now -97.17% below its all-time high of $23.14 million, reached on 31 December 2008.PTIX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$789.30 K
+$114.70 K+17.00%
30 September 2024
Summary:
Protagenic Therapeutics quarterly total current liabilities is currently $789.30 thousand, with the most recent change of +$114.70 thousand (+17.00%) on 30 September 2024. Over the past year, it has dropped by -$490.80 thousand (-38.34%). PTIX quarterly current liabilities is now -96.93% below its all-time high of $25.72 million, reached on 30 September 2008.PTIX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.5% | -38.3% |
| 3 y3 years | +0.0% | +9.0% |
| 5 y5 years | -27.8% | +21.2% |
PTIX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -41.5% | +0.0% | -47.6% | +76.9% |
| 5 y | 5 years | -45.3% | +0.0% | -47.6% | +76.9% |
| alltime | all time | -97.2% | +593.4% | -96.9% | +2679.2% |
Protagenic Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $789.30 K(+17.0%) |
| June 2024 | - | $674.60 K(+51.2%) |
| Mar 2024 | - | $446.10 K(-31.9%) |
| Dec 2023 | $655.30 K(-41.5%) | $655.30 K(-48.8%) |
| Sept 2023 | - | $1.28 M(-15.0%) |
| June 2023 | - | $1.51 M(+20.2%) |
| Mar 2023 | - | $1.25 M(+11.8%) |
| Dec 2022 | $1.12 M(+40.1%) | $1.12 M(+102.3%) |
| Sept 2022 | - | $553.50 K(+19.5%) |
| June 2022 | - | $463.10 K(-40.9%) |
| Mar 2022 | - | $783.60 K(-2.0%) |
| Dec 2021 | $799.50 K(+22.0%) | $799.50 K(+10.4%) |
| Sept 2021 | - | $724.40 K(+20.2%) |
| June 2021 | - | $602.60 K(-7.4%) |
| Mar 2021 | - | $651.00 K(-0.6%) |
| Dec 2020 | $655.20 K(-45.3%) | $655.20 K(-8.0%) |
| Sept 2020 | - | $712.10 K(-11.0%) |
| June 2020 | - | $799.90 K(-2.9%) |
| Mar 2020 | - | $824.20 K(-31.2%) |
| Dec 2019 | $1.20 M(+31.9%) | $1.20 M(+83.9%) |
| Sept 2019 | - | $651.00 K(-10.7%) |
| June 2019 | - | $729.20 K(-11.8%) |
| Mar 2019 | - | $826.60 K(-8.9%) |
| Dec 2018 | $907.80 K(+61.6%) | $907.80 K(+36.0%) |
| Sept 2018 | - | $667.40 K(+25.3%) |
| June 2018 | - | $532.50 K(+5.6%) |
| Mar 2018 | - | $504.10 K(-10.3%) |
| Dec 2017 | $561.70 K(-18.0%) | $561.70 K(+4.6%) |
| Sept 2017 | - | $536.90 K(-7.1%) |
| June 2017 | - | $578.10 K(-2.5%) |
| Mar 2017 | - | $592.80 K(-13.4%) |
| Dec 2016 | $684.90 K(+262.4%) | $684.90 K(+5.6%) |
| Sept 2016 | - | $648.30 K(+7.5%) |
| June 2016 | - | $603.10 K(-18.1%) |
| Mar 2016 | - | $736.00 K(-17.5%) |
| Dec 2015 | - | $892.00 K(+16.3%) |
| Sept 2015 | - | $767.00 K(+305.8%) |
| June 2015 | $189.00 K(+34.0%) | $189.00 K(-68.6%) |
| Mar 2015 | - | $602.00 K(+2.2%) |
| Dec 2014 | - | $589.00 K(+35.4%) |
| Sept 2014 | - | $435.00 K(+208.5%) |
| June 2014 | $141.00 K(-99.2%) | $141.00 K(-99.3%) |
| June 2013 | $18.18 M(+77.1%) | - |
| Sept 2011 | - | $18.82 M(+23.6%) |
| June 2011 | - | $15.23 M(+58.3%) |
| Mar 2011 | - | $9.63 M(-6.2%) |
| Dec 2010 | $10.26 M | $10.26 M(+10.0%) |
| Sept 2010 | - | $9.33 M(-22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $12.07 M(-19.2%) |
| Mar 2010 | - | $14.94 M(-9.8%) |
| Dec 2009 | $16.57 M(-28.4%) | $16.57 M(-18.6%) |
| Sept 2009 | - | $20.34 M(+6.8%) |
| June 2009 | - | $19.05 M(-20.5%) |
| Mar 2009 | - | $23.95 M(+3.5%) |
| Dec 2008 | $23.14 M(+227.1%) | $23.14 M(-10.0%) |
| Sept 2008 | - | $25.72 M(+44.4%) |
| June 2008 | - | $17.80 M(-21.7%) |
| Mar 2008 | - | $22.75 M(+221.5%) |
| Dec 2007 | $7.08 M(+65.7%) | $7.08 M(-0.7%) |
| Sept 2007 | - | $7.13 M(+57.8%) |
| June 2007 | - | $4.52 M(-6.8%) |
| Mar 2007 | - | $4.85 M(>+9900.0%) |
| Dec 2006 | $4.27 M(+2326.7%) | - |
| Oct 2006 | - | $28.40 K(-83.9%) |
| July 2006 | - | $176.00 K(+1.4%) |
| July 2006 | $176.00 K(+86.2%) | - |
| Apr 2006 | - | $173.50 K(+6.8%) |
| Jan 2006 | - | $162.50 K(+11.1%) |
| Oct 2005 | - | $146.30 K(-98.4%) |
| July 2005 | $94.50 K(-78.0%) | - |
| July 2004 | $430.00 K(-95.0%) | - |
| Apr 2003 | - | $9.15 M(+10.0%) |
| Jan 2003 | - | $8.32 M(-6.7%) |
| Oct 2002 | - | $8.91 M(+3.0%) |
| July 2002 | $8.65 M(-10.8%) | $8.65 M(-2.4%) |
| Apr 2002 | - | $8.87 M(-13.3%) |
| Jan 2002 | - | $10.22 M(-4.3%) |
| Oct 2001 | - | $10.68 M(+10.0%) |
| July 2001 | $9.71 M(+13.1%) | $9.71 M(+0.8%) |
| Apr 2001 | - | $9.63 M(+9.5%) |
| Jan 2001 | - | $8.80 M(+1.9%) |
| Oct 2000 | - | $8.63 M(+0.6%) |
| July 2000 | $8.58 M(-11.1%) | $8.58 M(+0.8%) |
| Apr 2000 | - | $8.52 M(-9.2%) |
| Jan 2000 | - | $9.38 M(+6.6%) |
| Oct 1999 | - | $8.80 M(-8.9%) |
| July 1999 | $9.66 M(+28.3%) | $9.66 M(+9.8%) |
| Apr 1999 | - | $8.80 M(-10.2%) |
| Jan 1999 | - | $9.80 M(+21.0%) |
| Oct 1998 | - | $8.10 M(+7.6%) |
| July 1998 | $7.53 M(+201.2%) | $7.53 M(+9.1%) |
| Apr 1998 | - | $6.90 M(-4.2%) |
| Jan 1998 | - | $7.20 M(+157.1%) |
| Oct 1997 | - | $2.80 M(+12.0%) |
| July 1997 | $2.50 M | $2.50 M(-19.4%) |
| Apr 1997 | - | $3.10 M(+55.0%) |
| Jan 1997 | - | $2.00 M |
FAQ
- What is Protagenic Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual current liabilities year-on-year change?
- What is Protagenic Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly current liabilities year-on-year change?
What is Protagenic Therapeutics annual total current liabilities?
The current annual current liabilities of PTIX is $655.30 K
What is the all time high annual current liabilities for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual total current liabilities is $23.14 M
What is Protagenic Therapeutics annual current liabilities year-on-year change?
Over the past year, PTIX annual total current liabilities has changed by -$464.60 K (-41.49%)
What is Protagenic Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of PTIX is $789.30 K
What is the all time high quarterly current liabilities for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly total current liabilities is $25.72 M
What is Protagenic Therapeutics quarterly current liabilities year-on-year change?
Over the past year, PTIX quarterly total current liabilities has changed by -$490.80 K (-38.34%)